Diabetes insipidus



Diabetes insipidus (DI) is the deficiency or resistance to the hormone vasopressin (antidiuretic hormone), which results in polyuria and polydipsia.
Epidemiology
DI occurs in 3 per 100,000 people .
Pathology
DI may be described as :
- central/neurogenic/hypothalamic: vasopressin deficient (more common)
- peripheral/nephrogenic: vasopressin resistant
Etiology
- central DI: reduced secretion of vasopressin
- trauma
- neurosurgery
- malignancy, e.g. craniopharyngioma, germinoma, metastases
- autoimmune disease, e.g. lymphocytic hypophysitis
- inflammatory disease, e.g. sarcoidosis, Langerhans cell histiocytosis, IgG4-related
- infection, e.g. tuberculosis
- pregnancy
- familial (rare)
- idiopathic
- peripheral DI: increased end-organ resistance to vasopressin
- congenital renal insensitivity to vasopressin (rare)
- long-term lithium use (15% of patients)
- metabolic, e.g. hypokalemia, hypercalcemia
- chronic kidney disease
- pregnancy
Treatment and prognosis
Desmopressin can be used to treat central DI .
Siehe auch:
- Syndrom der inadäquaten ADH-Sekretion (SIADH)
- Bartter-Syndrom
- Diabetes insipidus renalis
- Diabetes insipidus centralis